Savara Inc (SVRA) stock
SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.72+0.24 (+5.36%)
Close on Nov 18, 2026Market cap $969.77MP/E –Yield –
Savara revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Savara's revenue for the twelve months ending Dec 31, 2020 was $257.00K. For fiscal 2020 it was $257.00K. The highest annual figure on record is $488.96K in fiscal 2010.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $257.00K | – |
| FY2019 | Dec 31, 2019 | $0 | – |
| FY2017 | Dec 31, 2017 | $0 | -100.0% |
| FY2016 | Dec 31, 2016 | $400.00K | +640.7% |
| FY2015 | Dec 31, 2015 | $54.00K | – |
| FY2014 | Dec 31, 2014 | $0 | – |
| FY2013 | Dec 31, 2013 | $0 | – |
| FY2012 | Dec 31, 2012 | $0 | -100.0% |
| FY2010 | Dec 31, 2010 | $488.96K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2021 | Sep 30, 2021 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | $1.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $256.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
| Q1 FY2020 | Mar 31, 2020 | $0 | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
| Q1 FY2019 | Mar 31, 2019 | $0 | -100.0% |
| Q1 FY2018 | Mar 31, 2018 | $0 | -100.0% |
| Q4 FY2017 | Dec 31, 2017 | $0 | -100.0% |
| Q3 FY2017 | Sep 30, 2017 | $0 | – |
| Q1 FY2017 | Mar 31, 2017 | $94.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $400.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $45.00K | – |
See a number that looks wrong?